NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Cardinal Health 110, LLC. DBA Leader | f1cd0d59-12a8-4ff2-942a-6faa6907ef05 | 2026-07-13 | Warnings | M013 362O9ITL9D |
| Aspirin | ASPIRIN | Amerisource Bergen | 2c5e80e8-a979-45fb-9297-8ff294280c25 | 2026-07-13 | Warnings | M013 |
| SINUS AND HEADACHE | ACETAMINOPHEN, PHENYLEPHRINE HCL | Rite Aid Corporation | efaf3be1-ab39-45f7-a45c-7fea8705c8d0 | 2026-07-10 | Warnings | 362O9ITL9D |
| INFANTS PAIN AND FEVER | ACETAMINOPHEN | Amazon.com Services LLC | 112076c4-cac2-45ab-9c77-5573edae7180 | 2026-07-10 | Warnings | M013 362O9ITL9D |
| Aspirin | ASPIRIN | Wal-Mart Stores Inc | 8ae16aa2-54bc-4c1a-aa36-93524199a67b | 2026-07-09 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Wildman Business Group | 943c8f49-e65e-40bc-b364-3274df4d21a2 | 2026-07-09 | Warnings | M013 362O9ITL9D |
| The Original Mane n Tail Daily Control 2 in 1 Anti Dandruff | PYRITHIONE ZINC | Straight Arrow Products Inc | 68ab55d6-b1a9-46c0-87f0-ec12ad3474bc | 2026-07-09 | Warnings | M |
| Sinus Congestion and Pain Maximum Strength | ACETAMINOPHEN, PHENYLEPHRINE HCL | Rugby Laboratories | fc42e97d-1224-4d29-a55d-1a1885e0bf8f | 2026-07-09 | Warnings | 362O9ITL9D |
| Aspirin Regular Strength | ASPIRIN | FOODHOLD U.S.A., LLC | 9e09b4fb-e015-45ea-8b1c-27faf65572aa | 2026-07-09 | Warnings | M013 |
| Tension Headache Relief | ACETAMINOPHEN, CAFFEINE | Walgreen Company | f13fb7e9-50ea-4e2c-a442-38b1b5b315d7 | 2026-07-09 | Warnings | M013 362O9ITL9D |
| Head Congestion and Mucus | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Cardinal Health 110, LLC. DBA Leader | 7418d92d-a540-40d6-91d0-b7eb1f87f8ff | 2026-07-08 | Warnings | 362O9ITL9D |
| Acetaminophen 500 Pyrilamine Maleate 15 and Caffeine 60 | ACETAMINOPHEN 500MG PYRILAMINE MALEATE 15MG AND CAFFEINE 60MG TABLETS | Health Pharma USA LLC | 34eb8a9b-d0ee-13e8-e063-6294a90a2fef | 2026-07-08 | Warnings | M013 |
| Acetaminophen 250 mg Aspirin 250 mg Caffeine 65 mg | ACETAMINOPHEN 250 MG ASPIRIN 250 MG CAFFEINE 65 MG | Health Pharma USA LLC | 3590d417-272b-ae4d-e063-6394a90a5dc6 | 2026-07-08 | Warnings | M013 |
| GOODMEDS EXTRA STRENGTH PAIN RELIEF ACETAMINOPHEN | ACETAMINOPHEN | Cabinet Health P.B.C. | 88884253-5a79-4ac1-b8ce-03966d8b509d | 2026-07-08 | Warnings | M013 362O9ITL9D |
| nighttime cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 24c22c9f-0c2f-46dc-850e-ed05f00d3e95 | 2026-07-08 | Warnings | 362O9ITL9D |
| NITETIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Meijer, Inc. | 0e65c5d1-a18b-452c-9be6-8d44d34577e9 | 2026-07-08 | Warnings | 362O9ITL9D |
| nighttime severe cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 7cb9f378-5d64-475f-bf26-4058ba6c15b4 | 2026-07-08 | Warnings | 362O9ITL9D |
| DG HEALTH DAY TIME INTENSE FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE | Dolgencorp Inc | f174d08e-3335-4cc9-8766-4070f18c4f31 | 2026-07-08 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Health Pharma USA LLC | 671adabe-5f82-4599-a133-3f67ccb34079 | 2026-07-07 | Warnings | M013 313782 362O9ITL9D |
| Pain Reliever Plus | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Rugby Laboratories | c3df1652-96a8-6043-e053-2995a90a2d26 | 2026-07-07 | Warnings | M013 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.